Progressive cerebral volume loss in human immunodeficiency virus infection: A longitudinal volumetric magnetic resonance imaging study

Archives of Neurology

Volumn 55, Issue 2, 1998, Pages 161-168

  Stout, Julie C ^a   Ellis, Ronald J ^b   Jernigan, Terry L ^b   Archibald, Sarah L ^b   Abramson, Ian ^b   Wolfson, Tanya ^b   Allen McCutchan, J ^b   Wallace, Mark R ^b   Hampton Atkinson, J ^b   Grant, Igor ^b  

^a INDIANA UNIVERSITY   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

CD4 ANTIGEN;

ARTICLE; BRAIN SIZE; CONTROLLED STUDY; DIAGNOSTIC VALUE; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HUMAN TISSUE; IMAGE ANALYSIS; MAJOR CLINICAL STUDY; MALE; NEUROANATOMY; NEUROLOGICAL COMPLICATION; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; PROGNOSIS; VOLUMETRY;

ADULT; ATROPHY; BRAIN; CD4 LYMPHOCYTE COUNT; COHORT STUDIES; DISEASE PROGRESSION; FLOW CYTOMETRY; HIV SEROPOSITIVITY; HUMANS; IMAGE PROCESSING, COMPUTER-ASSISTED; LONGITUDINAL STUDIES; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; SEVERITY OF ILLNESS INDEX;

EID: 0031935008     PISSN: 00039942     EISSN: None     Source Type: Journal    
DOI: 10.1001/archneur.55.2.161     Document Type: Article

References (38)

1. Price R, Brew B. The AIDS dementia complex. J Infect Dis. 1988;158:1079-1083.
2. Grant I, Heaton R, Atkinson J, and the HNRC Group. Neurocognitive disorders in HIV-1 infection. Curr Top Microbiol Immunol. 1995;202:11-32.
3. Navia B, Jordan B, Price R. The AIDS dementia complex, I: clinical features. Ann Neurol. 1986;19:517-524.
4. Ho D, Rota T, Schooley R, et al. Isolation of HTLV-III from cerebrospinal fluid and neural tissues of patients with neurologic syndromes related to the acquired immunodeficiency syndrome. N Engl J Med. 1985;313:1493-1497.
5. Levy J, Shimabukuro J, Hollander H, Mills J, Kaminsky L. Isolation of AIDS-associated retroviruses from cerebrospinal fluid and brain of patients with neurological symptoms. Lancet, 1985;2:586-588.
6. Ellis R, Deutsch R, Heaton R, et al. Neurocognitive impairment is an independent risk factor for death in HIV infection. Arch Neurol. 1997;54:416-424.
7. Spencer D. Human Immunodeficiency virus type-1 and tuberculosis in an urbanized, hospitalised community in Johannesburg, South Africa. Nursing RSA. 1992;7:39.
8. Price R, Understanding the AIDS dementia complex (ADC): the challenge of HIV and its effects on the central nervous system, Res Publ Assoc Res Nerv Ment Dis. 1994;72:1-45.
9. Lipton S, Gendelman H. Dementia associated with the acquired immunodeficiency syndrome. N Engl J Med. 1995;665:934-940.
10. Dal Pan G, McArthur J, Aylward E, et al. Patterns of cerebral atrophy in HIV-1-infected individuals: results of a quantitative MRI analysis. Neurology. 1992;42:2125-2130.
11. Raininko R, Elovaara I, Virta A, Valanne L, Haltia M, Valle S. Radiological study of the brain at various stages of human immunodeficiency virus infection: early development of brain atrophy. Neuroradiology. 1992;34:190-196.
12. Post M, Berge J, Quence R. Asymptomatic and neurologically symptomatic HIV-seropositive individuals: prospective evaluation with cranial MR imaging. Radiology. 1991;178:131-139.
13. Moeller A, Backmund H. Ventricle brain ratio in the clinical course of HIV infection. Acta Neurol Scand. 1990;81:512-515.
14. Jakobsen J, Gyldensted C, Brun B, Bruhn P, Helweg-Larsen S, Arlien-Soborg P. Cerebral ventricular enlargement relates to neuropsychological measures in unselected AIDS patients. Acta Neurol Scand, 1989;79:59-62.
15. Elovaara I, Poutiainen E, Raininko R, et al. Mild brain atrophy in early HIV infection: the lack of association with cognitive deficits and HIV-specific intrathecal immune response. J Neurol Sci. 1990;99:121-136.
16. Aylward E, Henderer J, McArthur J, et al. Reduced basal ganglia volume in HIV-1-associated dementia: results from quantitative neuroimaging. Neurology. 1993;43:2099-2104.
17. Aylward E, Brettschneider P, McArthur J, et al. Magnetic resonance imaging measurement of gray matter volume reductions in HIV dementia. Am J Psychiatry. 1995;152:987-994.
18. Jernigan T, Archibald S, Hesselink J, et al. Magnetic resonance imaging morphometric analysis of cerebral volume loss in human immunodeficiency virus infection. Arch Neurol. 1993;50:250-255.
19. Bornstein R, Chakeres D, Brogan M, et al. Magnetic resonance imaging of white matter lesions in HIV infection. J Neuropsychiatry Clin Neurosci. 1992;4:174-178.
20. Grant I, Atkinson J, Hesselink J, et al. Evidence for early central nervous system involvement in the acquired immunodeficiency syndrome (AIDS) and other human immunodeficiency virus (HIV) infections. Ann Intern Med. 1987;107:828-836.
21. Hesselink J, Jernigan T, Heindel W. Structural brain imaging of HIV infection. In: Grant I, Martin A, eds. Neuropsychology of HIV Infection. New York, NY: Oxford University Press Inc; 1994:108-130.
22. Heindel W, Jernigan T, Archibald S. Achim C. Masliah E, Wiley C. The relationship of quantitative brain magnetic resonance imaging measures to neuropathologic indexes of human immunodeficiency virus infection. Arch Neurol. 1994;51:1129-1135.
23. Navia BA. The AIDS dementia complex. In: Cummings JL, ed. Subcortical Dementis. New York, NY: Oxford University Press Inc; 1990:181-198.
24. Heaton R, Grant I. Butters N, et al. The HRNC 500: neuropsychology of HIV infection at different disease stages. J Int Neuropsychol Soc. 1995;1:231-251.
25. Peavy G, Jacobs D, Salmon D, et al. Verbal memory performance of patients with human immunodeficiency virus infection: evidence of subcortical dysfunction. J Clin Exp Neuropsychol. 1994;16:508-523.
26. Stout J, Salmon D, Butters N, et al. Decline in working memory associated with HIV infection. Psychol Med. 1995;25:1221-1232.
27. Martin A. HIV, cognition, and the basal ganglia, In: Grant I, Martin A, eds. Neuropsychology of HIV Infection, New York, NY; Oxford University Press Inc; 1994:234-259.
28. Centers for Disease Control. 1993 revised classification system for HIV infection and expanded surveillance case definition for AIDS among adolescents and adults. MMWR Morb Mortal Wkly Rep. 1992;41:1-19.
29. Giorgi J. Characterization of T lymphocyte subset alterations by flow cytometry in HIV disease. Ann N Y Acad Sci. 1993;677:126-137.
30. Cavalli G, Lopez S, Franzetti F, et al. Diagnostic and prognostic significance of beta 2-microglobulin during HIV infection, Ric Clin Lab. 1990;20:105-111.
31. Phillips A, Sabin C, Elford J, et al. Serum beta 2-microglobulin at HIV-1 seroconversion as a predictor of severe immunodeficiency during 10 years of followup, J Acquir Immune Defic Syndr Hum Retrovirol. 1996;13:262-266.
32. Collier A, Coombs R, Schoenfeld D, et al. Treatment of human immunodeficiency virus infection with saquinavir, zidovudine, and zalcitabine, N Engl J Med. 1996;334:1011-1017.
33. Jacobson M, De Gruttola V, Reddy M, et al. The predictive value of changes in serologic and cell markers of HIV activity for subsequent clinical outcome in patients with asymptomatic HIV disease treated with zidovudine. AIDS. 1995;9:727-734.
34. Jernigan T, Hesselink J, Sowell E, Tallal P. Cerebral structure on magnetic resonance imaging in language- and learning-impaired children. Arch Neurol. 1991;48:539-545.
35. Abramson I. A recursive regression for high-dimensional models, with applications to growth curves and repeated measures. J Am Stat Assoc, 1988;83:1073-1077.
36. Hall M, Whaley R, Robertson K, Hamby S, Wilkins J, Hall C. The correlation between neuropsychological and neuroanatomic changes over time in asymptomatic and symptomatic HIV-1-infected individuals. Neurology. 1996;46:1697-1702.
37. Wiley C, Masliah E, Achim C. Measurement of CNS HIV burden and its association with neurologic damage. Adv Neuroimmunol. 1994;4:319-325.
38. Brew B, Rosenblum M, Cronin K, Price R. AIDS dementia complex and HIV-1 brain infection: clinical-virological correlations. Ann Neurol. 1995;38:563-570.